Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Nova Complex Showcases European Green Infrastructure Strategy at Datacloud Global Congress 2026
-
Umbrella Lab Announces Documentation And Traceability Update For Bromantane Reference Material
-
3 E Network Enters Strategic Framework Agreement with California-Based Aladdin Alaris AI to Explore Next-Generation Healthcare and Eldercare Robotics
-
Net Asset Value(s)
-
The Edge Negotiation Group Launches Deal/Spar, an AI-Powered Negotiation Simulator for Voice and Text-Based Practice
-
The Hemp Tax: Why Industrial Hemp Can’t Afford to Sit This One Out[
-
Midland Identifies Several Lake Bottom Copper Anomalies from Its New High-Resolution Survey Completed on the Lac Bernard Project
-
Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer
-
Tris Pharma to Present on Dual NOP/MOP Receptor Agonist in Pain Management and Substance Use Disorder at the College on Problems of Drug Dependence (CPDD) 88th Annual Scientific Meeting, 2026
-
North American Niobium to Fly Airborne Survey Over Four Québec Properties
-
FLUENT Provides Management Update
-
QGold Provides Update on Acceleration of Warrants
-
Spinach® is the Number One Vape Brand in Canada
-
Brixton Metals Commences 2026 Thorn Project Exploration Program
-
Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program
-
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results
-
Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference
-
Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer
-
zerohash Adds Support for HYPE, USDC.HYPE, and USDT.HYPE, Expanding Access for One of the Fastest-Growing Technology Ecosystems
-
Swarmer Publishes Letter From Its Chairman, Erik Prince, Outlining Strategy
-
Quantum Cyber Entering Steady-State Scale Production, Launches Vertically Integrated Advanced Filament Manufacturing Division
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
In tomorrow’s AI economy, what’s the role of humans?
-
Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026
-
Toobit Rewards Traders with VIP Benefits and Over 1,000 USDT
-
The World Cup Effect: Superprof Survey Finds American Families Are Getting Excited About World Cultures
-
Labrador Gold to Host Investor Webinar on the Mariposa Gold Project in Yukon’s White Gold District
-
Kyivstar’s Uklon Launches Marketplace, Starting with Flower Delivery
-
Xali Gold Announces Non-Brokered Financing
-
Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy
-
Joveo Named Strategic Challenger on 2026 Fosway 9-Grid™ for Talent Acquisition
-
Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
-
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
-
Syndax Announces Publication of SAVE Data on Revuforj® (revumenib) in Combination with Decitabine/Cedazuridine and Venetoclax in Relapsed/Refractory NPM1m, KMT2Ar, and NUP98r AML in the Journal of Cl
-
Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms
-
Troilus Continues to Expand High-Grade West Rim Discovery With 19.06 g/t AuEQ Over 6.4 m and 6.81 g/t AuEQ Over 5 m at Surface
-
Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
-
GURU Organic Energy Delivers 31.6% Revenue Growth and Continued Margin Expansion in Second Quarter 2026
-
Lithium Ionic Initiates Long-Lead Order and Provides Community Engagement Update
-
Edibles.com Names Thomas Winstanley President to Drive Next Phase of Growth
-
Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026
-
Aqua Metals Selected as Industrial Partner on DOE-Funded Idaho National Laboratory Program Advancing Critical Minerals Refining
-
Verano Completes 1-for-5 Reverse Stock Split, Advancing the Company’s Path Towards Prospective U.S. Stock Exchange Listing
-
C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pret
-
BrewDog Rolls Back Pint Prices to £2 Across Scotland for 72-Hour Bank Holiday Weekend, Celebrating the National Team’s Return
-
The Lovesac Company Reports First Quarter Fiscal 2027 Financial Results
-
Neion Bio Raises Oversubscribed $23 Million Series A to Advance Biologics Manufacturing Platform and Expand Pipeline
-
Bereaved Mothers Give a Gift to Every Grieving Father: The “All Fathers Day” Free Grief Support Bundle. A Documentary Film. A Live Father’s Day Support Group. Free Online Courses. A Dedicated Co
-
BlossomHill Therapeutics Presents Initial Clinical Data from Dose Escalation in Ongoing Phase 1/1b Trial of Novel Macrocyclic CLK Inhibitor, BH-30236, in Patients with R/R AML or HR-MDS at EHA 2026
-
Kyivstar’s Uklon Launches Marketplace, Marking Strategic Entry into E-Commerce and Accelerating Ecosystem Monetization
